Abstract
1-[(E)-2-(4-bromophenyl)-1-diazenyl]-3-({3-[(E)-2-(4-bromophenyl)-1-diazenyl]-6-ethylhexahydro-1-pyrimidinyl}methyl)-4-ethylhexahydropyrimidine (1) has been synthesized by reaction of a mixture of formaldehyde and 1,3-pentanediamine{DYTEK®EPdiamine} with p-bromobenzenediazonium chloride. This compound crystallizes in two polymorphic forms 1-α and 1-β whose crystal structures have been determined by single crystal X-ray diffraction analysis. Both polymorphs 1-α and 1-β display crystallographic disorder within the hexahydropyrimidine rings. The molecule of 1 is built up of two equivalent 3-(aryldiazenyl)-6-ethylhexahydro-1-pyrimidinyl groups in the s-trans orientation around the central methylene group (C13). In both structures the triazene moieties adopt the anti configuration around the N=N bonds, displaying significant π-conjugation. The crystal packings are determined only by van der Waals interactions. The crystal structures of 1-α and 1-β are compared with the previously reported structure of the 5,5-dimethylhexahydropyrimidine analogue 3. Compounds 1 and 3 are isomeric with respect to the hexahydropyrimidine moiety. The structures of 1 and 3 are very different in one respect; in 1 the aryldiazenyl-hexahydropyrimidinyl groups are in the s-trans orientation around the central methylene group, whereas in 3 the arrangement of the aryldiazenylhexahydropyrimidinyl groups is the s-cis orientation. Crystal data: 1-α C25H34N8Br2, monoclinic, space group P2(1)/c, a = 9.2150(3), b = 19.4059(6), c = 15.4324(5) Å, β = 98.738(1)∘, V = 2727.7(2) Å3, for Z = 4; 1-β C25H34N8Br2, triclinic, space group P-1, a = 9.6009(3), b = 10.7509(4), c = 14.2169(5) Å, α = 99.830(2), β = 105.973(3), γ = 95.578(1)∘, V = 1373.9(1) Å3, for Z = 2.
Similar content being viewed by others
References
Hooper, D.L.; Peori, M.B.; Vaughan, K. J. Org. Chem. 1998, 63, 7437.
Glister, J.F.; Vaughan, K.; Bertolasi, V. J. Chem. Cryst. 2004, 34, 175.
Peori, B., Vaughan, K.; Bertolasi, V. J. Chem. Cryst. 2004, 35(4), 301–309.
Moser, S.L.; Bertolasi, V.; Vaughan, K. J. Chem. Cryst. 2005, 35(4), 311–316.
Tingley, R.; Peori, M.B.; Church, R.; Vaughan, K. Can. J. Chem. 2005, in press.
Otwinowski, Z.; Minor, W. In Methods in Enzymology; Vol. 276, Part A, Carter, C.W.; Sweet, R.M., Eds.; Academic Press: London, 1997, pp 307–326.
Blessing, R.H. Acta Crystallogr. 1995, A51, 33.
Altomare, A.; Burla, M.C.; Camalli, M.; Cascarano, G.; Giacovazzo, C.; Guagliardi, C.; Moliterni, A.G.; Polidori, C.; Spagna, R. J. Appl. Crystallogr. 1999, 32, 115.
Sheldrick, G.M. SHELXL-97, Program for Refinement of Crystal Structures; University of Göttingen: Germany, 1997.
Nardelli, M. J. Appl. Crystallogr. 1995, 28, 659.
Burnett, M.N.; Johnson, C.K. ORTEP-III, Report ORNL-6895 Oak Ridge National Laboratory, Oak Ridge, TN, 1996.
Allen, F.H.; Kennard, O.; Watson, D.G.; Brammer, G.; Orpen, G.; Taylor, R. J. Chem. Soc. Perkin Trans. 1987, 2, S1.
Cremer, D.; Pople, J.A. J. Am. Chem. Soc. 1975, 97, 1354.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tingley, R., Bertolasi, V. & Vaughan, K. X-ray crystal structures of two polymorphic forms, monoclinic and triclinic, of: 1-[(E)-2-(4-bromophenyl)1-diazenyl]-3-({3-[(E)-2-(4-bromophenyl)-1-diazenyl]-6-ethylhexahydro-1-pyrimidinyl}methyl)-4-ethylhexahydropyrimidine. J Chem Crystallogr 35, 821–828 (2005). https://doi.org/10.1007/s10870-005-4552-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10870-005-4552-y